Eugenia V. Trushina
Mayo Clinic
Also published as: Eugenia Trushina
7 papersORCID 0000-0002-6291-2860OpenAlex
- Mitochondrion
- Oxidative phosphorylation
- Complex I inhibitors
- Nad(h) precursor
- Alzheimer's disease
- APP
- MAPT
- Integrated stress response
Is this you? Claim this profile
Papers
AAIC 2025 Abstract
Partial Mitochondrial Complex I Inhibitors as a Therapy for Alzheimer Disease
Experiments in animalsInterventions
AAIC 2025 Abstract
Preliminary Study of Low Dose Minibeam Radiation Therapy in a Murine Model of Alzheimer's Disease
Experiments in animalsInterventions
Acta Pharmaceutica Sinica B
Mitochondrial complex I as a therapeutic target for Alzheimer's disease
ReviewAlzheimer's disease
Cell Reports
NAD depletion mediates cytotoxicity in human neurons with autophagy deficiency
Experiments in cellsMechanisms
Nature Reviews Drug Discovery
Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing
ReviewInterventions
bioRxiv
Autophagy promotes cell and organismal survival by maintaining NAD(H) pools
Preprint: experiments in yeastInterventions
EBioMedicine
White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer's Disease
Experiments in animalsMechanisms
Works at
Lead investigator
Sources: openalex.org
Grants and prizes
Alzheimer's Drug Discovery Foundation
Drug Discovery, Small Molecule Inhibitors of Mitochondrial Complex I for Treatment of Alzheimer's Disease, ADDF-3952, 2018–2020, Jan 11, 2018
Sources: openalex.org